BPC-157: origin and mechanism
BPC-157 peptide ("Body Protection Compound-157") comes from a protein naturally found in human gastric juice. It's studied for one main reason: its apparent effect on angiogenesis — new blood vessel formation — and the growth-factor pathways that drive tissue repair.
TB-500: mechanism and why it's paired with BPC-157
TB-500 is a fragment of Thymosin Beta-4, studied for its role in actin regulation — the mechanism behind cell migration. BPC-157 works on growth-factor signaling, TB-500 works on cell migration. Different mechanisms, same end goal, which is exactly why research protocols so often run them together.
Why people research BPC-157 peptide and TB-500
Tendon, ligament, and joint injuries are the single biggest reason this pair gets studied — specifically the chronic, slow-healing kind that don't respond well to standard recovery timelines. That's what pulls in most of the sports-science and physical-therapy interest. A second, smaller thread comes straight from BPC-157's gastric origin: researchers studying gut-lining and digestive-tract repair, a separate use case from the orthopedic one. TB-500 rides along in both contexts, given how directly its mechanism complements BPC-157's.
BPC-157 / TB-500, ≥99% purity, independent COA on every lot. This is where our own research references point.
Injectable vs. capsule forms — two different markets
Worth being precise here: injectable, lyophilized BPC-157 (the subject of this guide) and oral capsule formulations are two distinct markets, with different bioavailability considerations and mostly separate suppliers. Don't assume research on one form carries over to the other.
Reading a certificate of analysis (COA)
A trustworthy COA states the testing method (HPLC and mass spectrometry), the measured purity percentage, the lot number, and the identity of the testing lab. Always cross-check the lot number printed on the vial against the COA published by the supplier.